So the Chemist WH stake is mainly for marketing? The amount of kavalactones in those pills would mean taking half the bottle almost + factoring in reverse tolerance issues... how does it promote repeat buys with such a slow and expensive entry?
18bucks on sale from 55bucks for those pills? And the numbers sold are still tiny.
The four pill products they sell too seem to have no true differentials re compounds. They market one for 'sleep', one for 'body' etc but there really isnt any difference.
Ashwaganda that is def more potent in pill form has no foothold here, even amongst the micro dosing community who rave re its nausea offsetting properties. It simply isn't a commonly used stack. And Kava doesnt even play into that daily use realm as it doesn't stack/offset with other microdose protocols.
The Coles product is 50g? What the RPP? 50g is so tiny and when education spreads re the amount required, surly it'll gain no true repeat market?
As for Kava bars... we simply don't have anything beyond a niche culture in a few suburbs like Brunswick etc that would setup a public option. Culturally, i can see a few bars opening and closing quickly due to those receptive areas having crazy high commercial rent. How do you add in other sellable elements too? Alcohol + food + music works, Kava doesn't have a companion product/service to sell in a bar setting at all.
Friends from Tonga have visited the US bars and find them underwhelming and sometimes crass. Each to their own, but I cant see it becoming even larger and hence putting a big demand on Fiji Kava to supply.
I'm glad the commercial stuff is opening up, but the products/front facing part of this business still makes no sense to me in terms of potential financial growth.
- Forums
- ASX - By Stock
- CCO
- Ann: First Approval for Importation of Drinking Kava
Ann: First Approval for Importation of Drinking Kava, page-34
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $19.81M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $27.87K | 3.094M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2282359 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 5228411 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2282359 | 0.009 |
17 | 3670831 | 0.008 |
16 | 6125151 | 0.007 |
5 | 1642133 | 0.006 |
6 | 10936969 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 5228411 | 18 |
0.011 | 11063271 | 14 |
0.012 | 11506404 | 6 |
0.013 | 4000000 | 1 |
0.014 | 500000 | 1 |
Last trade - 13.29pm 21/10/2024 (20 minute delay) ? |
Featured News
CCO (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online